Amlodipine in ischaemic left ventricular dysfunction with mild to moderate heart failure

Clinical Drug Investigation

Volumn 16, Issue 4, 1998, Pages 289-296

  Perna, Gian Piero ^a   Valle, Guido ^a   Cianfrone, Nicola ^a   De Luca, Giovanni ^a   Amico, Cesare ^a   Coli, Carlo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; THALLIUM 201;

ADULT; AEROBIC CAPACITY; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM; SYSTOLIC BLOOD PRESSURE; WORKLOAD;

EID: 0031770508     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816040-00003     Document Type: Article

References (23)

1. Pouleur H. Calcium antagonists or beta-blockers in chronic ischaemic left ventricular dysfunction? Eur Heart J 1993; 14: 26-8
2. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35
3. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine - isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-10
4. SOLVD investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293-302
5. Pfeffer MA, Braunwald E, Moyè LA, et al., on behalf of the SAVE investigators. Effect of caplopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327: 669-77
6. Feldman AM. Can we alter survival in patients with congestive heart failure? JAMA 1992; 267: 1956-61
7. Elkavam U, Sholan A, Mehera A. et al. Calcium channel blockers in heart failure. Am J Cardiol 1993; 22: 139A-144A
8. Parameshwar J, Poole-Wilson PA. The role of calcium antagonists in treatment of chronic heart failure. Eur Heart J 1993; 14 Suppl. F: 26-8
9. Packer M, Nicod P, Kandheria R, et al. Randomized, multicenter, double-blind, placebo controlled evaluation of amlodipine in patients with mild-to-moderate heart failure. J Am Coll Cardiol 1991; 17: 274A
10. Smith WB, DcAbate AC, Gollub SB, et al. Beneficial long-term hemodynamic and clinical effect of amlodipine in chronic-heart failure: results of a multicentric randomized, double blind, placebo controlled, dose-ranging study. Circulation 1994; 90: Suppl. 1: 603A
11. Packer M, O'Connor CM, Ghali JK, et al., for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996; 335: 1107-14
12. Pearlman AS, Gardin JM, Martin RP, el al. Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography. Committee lor Physician Training in Echocardiography. Am J Cardiol 1987; 60: 158-63
13. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 2nd ed. Pennsylvania: Lea & Febiger, 1994
14. Franciosa JA, Dunkman WB, Leddy CL. Hemodynamic effects of vasodilators and long-term response in heart failure. Am J Cardiol 1984; 3: 1521-30
15. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993; 87 Suppl. VI: 5-16
16. Bolli R. Myocardial stunning in man. Circulation 1992; 86: 1671-91
17. Vanoverschelde JLJ, Wijns W, Depré C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87: 1513-23
18. Rahimtoola SH. From coronary artery disease to heart failure: role of the hibernating myocardium. Am J Cardiol 1995; 75: 16E-22E
19. Ferrari R. Calcium antagonists and left ventricular dysfunction. Am J Cardiol 1995; 75: 71E-76E
20. Gross CJJ, Pieper GM. Beneficial actions of amlodipine in the multiple-stunned canine myocardium. Cardiovasc Drugs Ther 1992; 6: 67-75
21. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels. An unexpected mechanism of action of a calcium channel blocking agent. Circulation 1998; 97: 576-80
22. Mohler ER, Sorensen LC, Ghali JK, et al. Role of cytokines in the mechanism of action of amlodipine: the PRAISE heart failure trial. J Am Coll Cardiol 1997; 30: 35-41
23. Taylor SH. Usefulness of amlodipine for angina pectoris. Am J Cardiol 1994; 73: 28A-33A